CHALLENGE + REWARD
GREAT TOGETHER
PlaqueTec - finding vulnerable plaque
PlaqueTec was incorporated in June 2008 and is the quintessential example of a start-up company.
The company's highly innovative bio-sampling technology will not only aid in the identification of vulnerable plaques, but will also help in developing future treatment strategies. Known as the "silent killer", vulnerable plaque is one of the biggest causes of heart failure and PlaqueTec's prospective technology represents a truly exciting and significant opportunity in healthcare.
The team behind PlaqueTec is energetic, enthusiastic, and deeply committed to its seminal technology, which will address a large and continuously growing market.
Although PlaqueTec is not currently recruiting, the company offers huge prospect for future growth, and we urge you to watch this space regularly if you believe that you can bring real value to this organisation.